A novel cell penetrating aspartic protease inhibitor blocks processing and presentation of tetanus toxoid more efficiently than pepstatin A
- 1 December 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 364 (2) , 243-249
- https://doi.org/10.1016/j.bbrc.2007.09.114
Abstract
No abstract availableKeywords
Funding Information
- Deutscher Akademischer Austauschdienst
- Deutsche Forschungsgemeinschaft (512385, SFB 685)
- Higher Education Commision, Pakistan
This publication has 23 references indexed in Scilit:
- Protein Delivery by the Cell-Penetrating Peptide YTA2Bioconjugate Chemistry, 2006
- Mannose–pepstatin conjugates as targeted inhibitors of antigen processingOrganic & Biomolecular Chemistry, 2006
- Cell-penetrating peptides—A brief introductionBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Coexpression of CD25 and OX40 (CD134) Receptors Delineates Autoreactive T-cells in Type 1 DiabetesDiabetes, 2006
- Cell-penetrating PeptidesJournal of Biological Chemistry, 2003
- Efficiency of Protein Transduction Is Cell Type-dependent and Is Enhanced by Dextran SulfateJournal of Biological Chemistry, 2002
- Involvement of Cathepsin E in Exogenous Antigen Processing in Primary Cultured Murine MicrogliaPublished by Elsevier ,2002
- Cell-penetrating peptidesPublished by Elsevier ,2000
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin EEuropean Journal of Immunology, 1992